ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,109Medicare Part D Prescriptions Filled, Including Refills

Rank: 321 out of 1107

$486K Total Retail Price of All Prescriptions

Rank: 395 out of 1107

310 Patients Receiving at Least One Drug in Part D
67%Patients 65 Years and Older
85% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kentucky
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

17% of this provider’s 310 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

3% of this provider’s 6,593 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

33 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kentucky
HYDROCODONE-ACETAMINOPHEN 652 388 S3 1 1
LISINOPRIL 467 277 2 2
LEVOTHYROXINE SODIUM 417 309 3 3
HYDROCHLOROTHIAZIDE 319 241 4 11
PRAVASTATIN SODIUM 274 192 5 12
OMEPRAZOLE 271 140 6 4
SIMVASTATIN 266 169 7 5
ATENOLOL 251 181 8 19
METFORMIN HCL 232 167 9 8
AMLODIPINE BESYLATE 221 166 10 6
RANITIDINE HCL 196 146 11 21
METOPROLOL TARTRATE 188 136 12 10
FUROSEMIDE 186 110 13 7
NEXIUM 134 66 14 18
ATORVASTATIN CALCIUM 123 96 15 13
POLYETHYLENE GLYCOL 3350 112 90 16 46
POTASSIUM CHLORIDE 109 77 17 14
LANTUS 104 64 18 49
GLIPIZIDE 104 77 18 64
SERTRALINE HCL 100 87 20 20
WARFARIN SODIUM 99 67 21 15
JANUVIA 98 81 22 60
CLOPIDOGREL 96 66 23 28
AZITHROMYCIN 95 56 24 35
DOXYCYCLINE HYCLATE 94 70 25 128
METOPROLOL SUCCINATE 93 70 26 16
NAPROXEN 91 43 27 80
NOVOLOG 87 56 28 127
FLUTICASONE PROPIONATE 86 47 29 38
PROMETHAZINE HCL 83 33 R 30 44
CITALOPRAM HBR 76 29 31 17
CRESTOR 76 55 31 23
CARVEDILOL 75 56 33 27
MELOXICAM 71 37 34 25
TRAZODONE HCL 71 48 34 33
ISOSORBIDE MONONITRATE ER 69 26 36 34
DILTIAZEM 24HR CD 68 68 37 126
GABAPENTIN 67 43 38 9
PLAVIX 65 46 39 39
AMOXICILLIN 65 44 39 90
INSULIN SYRINGE 59 23 41 78
DONEPEZIL HCL 59 48 41 32
TRAMADOL HCL 59 44 41 26
TAMSULOSIN HCL 59 31 41 30
NIASPAN 58 32 45 125
COMBIVENT 57 47 46 112
LOSARTAN POTASSIUM 52 39 47 29
ALLOPURINOL 51 37 48 36
IBUPROFEN 50 31 49 63
LYRICA 50 40 49 83
CYCLOBENZAPRINE HCL 50 34 R 49 56
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 27, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.